OMRX (OMRX) Stock Price & Analysis
OMRX (OMRX) rose 0.00% to USD 0 as of July 25, 2026 at 13:41 UTC, according to Nexqual real-time market data.
OMRX last closed at USD 0; the session ranged USD 0–0 on volume of 800 shares. Market capitalization is $74,457, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, July 25, 2026 at 13:41 UTC.
Key Statistics (as of July 25, 2026 at 13:41 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 800 shares |
| Market Cap | $74,457 |
| Exchange | PNK |
Technical Analysis (OMRX)
Nexqual's technical model rates OMRX "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:41 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (OMRX)
Wall Street analysts rate OMRX "None", per Nexqual as of July 25, 2026 at 13:41 UTC.
| Consensus Rating | None |
|---|
Earnings (OMRX)
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Financials & Fundamentals (OMRX)
| Total Revenue | $1.46M |
|---|---|
| Revenue Growth (YoY) | -82.10% |
| Gross Margin | +40.57% |
| Operating Margin | -184.58% |
| Profit Margin | -65.85% |
| Current Ratio | 0.13 |
| Total Cash | $2,332 |
| Total Debt | $2.61M |
| Free Cash Flow | $-148,512 |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Financial Health Score (OMRX)
Nexqual rates OMRX's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:41 UTC.
| Growth | Critical — Revenue -82% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $2K cash vs $3M debt |
| Cash Flow | Weak — FCF negative: -$149K, burning cash |
| Efficiency | Mixed — No data |
Ownership (OMRX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 0 |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Leadership (OMRX)
OMRX is led by Reynald G. Bonmati M.Sc. Ch.E. (age 77), Founder, Chief Executive Officer, President, Treasurer and Chairman of the Board, per Nexqual as of July 25, 2026 at 13:41 UTC.
| Founder, Chief Executive Officer, President, Treasurer and Chairman of the Board | Reynald G. Bonmati M.Sc. Ch.E. (age 77) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIMU | Non-Invasive Monitoring Systems | USD 0.09 | ▲ 21.33% |
| OPTL | OPTIMUM INTERACTIVE USA LTD | USD 0 | ▲ 0% |
| ADLI | AMERICAN MEDICAL TECHNOLOGIES | USD 0 | ▲ 0% |
| POSC | Positron Corp. | USD 1.68 | ▲ 1.39% |
| NWCI | NEWCARDIO INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:41 UTC. This page is informational and not investment advice.